key: cord-1023276-uvarl3ov
authors: Moshkelgosha, Sajad; Duong, Allen; Wilson, Gavin; Andrews, Tallulah; Berra, Gregory; Renaud-Picard, Benjamin; Liu, Mingyao; Keshavjee, Shaf; MacParland, Sonya; Yeung, Jonathan; Martinu, Tereza; Juvet, Stephen
title: Interferon-stimulated and metallothionein-expressing macrophages are associated with acute and chronic allograft dysfunction after lung transplantation
date: 2021-06-15
journal: bioRxiv
DOI: 10.1101/2021.06.14.447967
sha: f4b3287fbe779c3e999a33cd82be0e96ba01f3e3
doc_id: 1023276
cord_uid: uvarl3ov

Lung transplant (LT) recipients experience episodes of immune-mediated acute lung allograft dysfunction (ALAD). ALAD episodes are a risk factor for chronic lung allograft dysfunction (CLAD), the major cause of death after LT. We have applied single-cell RNA sequencing (scRNAseq) to bronchoalveolar lavage (BAL) cells from stable and ALAD patients and to cells from explanted CLAD lung tissue to determine key cellular elements in dysfunctional lung allografts, with a focus on macrophages. We identified two alveolar macrophage (AM) subsets uniquely represented in ALAD. Using pathway analysis and differentially expressed genes, we annotated these as pro-inflammatory interferon-stimulated gene (ISG) and metallothionein-mediated inflammatory (MT) AMs. Functional analysis of an independent set of AMs in vitro revealed that ALAD AMs exhibited a higher expression of CXCL10, a marker of ISG AMs, and increased secretion of pro-inflammatory cytokines compared to AMs from stable patients. Using publicly available BAL scRNAseq datasets, we found that ISG and MT AMs are associated with more severe inflammation in COVID-19 patients. Analysis of cells from four explanted CLAD lungs revealed similar macrophage populations. Using a single nucleotide variation calling algorithm, we also demonstrated contributions of donor and recipient cells to all AM subsets early post-transplant, with loss of donor-derived cells over time. Our data reveals extensive heterogeneity among lung macrophages after LT and indicates that specific sub-populations may be associated with allograft dysfunction, raising the possibility that these cells may represent important therapeutic targets.

Lung transplantation (LT) is a life-saving treatment option for advanced lung disease (1), but 3 long-term survival after LT remains relatively poor, despite recent improvements (2). The main 4 factor limiting long-term survival is chronic lung allograft dysfunction (CLAD), a progressive 5 fibrotic process that destroys the lung allograft and is driven by inflammation and alloimmunity. 6

Primary graft dysfunction, acute cellular rejection, antibody-mediated rejection and infection are 7 among the main risk factors for CLAD, but how these insults drive CLAD development remains 8 unknown, because the cellular mechanisms that link these risk factors to organ fibrosis remain 9 incompletely understood. AMs play a critical role in maintaining pulmonary homeostasis through interactions with the 21 alveolar epithelium, and during acute inflammation by orchestrating pro-inflammatory and 22

profibrotic responses through phagocytosis and secretion of inflammatory cytokines and 23

reparative molecules (7-10). The ontogeny of AMs differs significantly between conditions of 24 homeostasis and inflammation. Murine studies suggest that most tissue resident AMs arise 25 during embryogenesis and self-maintain with a minimum contribution from peripheral 26 monocytes (11-13). In contrast, a single-cell RNA sequencing (scRNAseq) study of BAL cells 27 from sex-mismatched LT recipients showed that donor AMs in the human lung are replaced by 28 recipient monocyte-derived macrophages (14) . The use of scRNAseq to study AMs has the 29 potential to deepen our knowledge of this cell population by allowing us to uncover important 30 heterogeneity within it. 31 32 In recent years, scRNAseq has been applied to the study of lung cells including AM, both in 33 humans and in animal models (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . Two recent studies of BAL cells in patients with 19 infection have focused on tracking viral RNA in infected cells (25) and studying immune 35 responses to the disease (26) . Both reports revealed substantial differences between AMs from 36 patients with mild disease compared to those with illness. BAL cells have also been studied using 37 scRNAseq in transplant recipients (14) and healthy controls (15). However, to our knowledge, no 38 study has specifically examined the association between disease severity and AM transcriptional 39 states at single cell resolution. 40 1

Here, we applied scRNAseq to BAL cells from LT recipients with stable lung function or acute 2 lung allograft dysfunction (ALAD) and to cells from CLAD lung tissue to test the hypothesis that 3 pathogenetically important AM transcriptional states might emerge during lung allograft 4 dysfunction. We observed 14 distinct gene expression programs with evidence for functional 5 specialization of AMs in the BAL; further, two distinct inflammatory macrophage populations 6 seen only in ALAD BAL samples and CLAD lung tissue mirrored similar cellular states in a public 7 dataset of BAL samples obtained from patients with severe COVID-19. 8 9 1  2 Ethics statement: The study was approved by University Health Network Research Ethics Board 3

(15-9531). All participants provided written informed consent for sample collection and 4 analyses. 5 6

Study design and patient selection: Six (one female and five male) LT recipients were selected, 7 three with acute lung allograft dysfunction (ALAD, defined as a decrease in the forced 8 expiratory volume in one second [FEV1] by 10% or more from the maximum of the two 9 preceding FEV1 measurements) and three with stable lung function. Patients with suspected 10 infection (focal opacities on chest imaging and/or mucopurulent secretions at bronchoscopy) 11

were excluded. Demographic characteristics of the study participants are provided in Table 1 1  2  Functional diversity of AMs from patients with stable lung function  3  BAL samples were collected at varying post-LT times from patients who were either stable (n=3)  4 or experiencing ALAD (n=3) (Fig 1A and Table 1 ). Single cell transcriptomes from each sample 5 were analyzed separately, following standard quality control protocols (Fig S1) . We applied a 6 reference-based annotation algorithm (ClusterR) and manual analysis of the top differentially 7 expressed genes to identify cell populations (Fig S2A-C) , demonstrating that the samples 8 contained epithelial, endothelial and immune cells; most were AM. Cell-cell interaction analysis 9

using CellChat (27) suggested that interaction amongst AMs are stronger and more complicated 10 than between AMs and other cells (Fig S2D, E) . Given the predominance of AM over other cell 11 populations in the BAL samples, we next examined these cells in greater depth. 12 13

The total number of AMs in the 3 stable BAL samples ranged from 1769 to 4681. We randomly 14

selected a 1000-cell subset (downsample) of AMs from each stable sample to optimize integration. 15

Next, we used SCTransform (28) to integrate scRNAseq data from all three stable samples ( Fig  16  S3A ) and data from all three ALAD samples ( Fig S3B) to minimize batch effects arising from 17 different sequencing runs. Expression of known macrophage transcripts confirmed that the cells 18

were AMs (Fig S4) . Clustering revealed 12 subsets (Fig 1B) . We then integrated differentially 19 expressed genes and gene set enrichment analysis (GSEA) (Fig S5A) with data reported in the 20 literature to annotate each cluster based on either putative function or cycling status ( Fig S5B) . We 21 identified three clusters with specialized anti-microbial functions (PLAC8 + : extracellular pathogen 22 defense; IFI27 + : viral defense; CTNNB1 + : intracellular bacterial defense) (29-31), two with 23 specialized immune regulatory functions (SOD2 + : anti-inflammatory, CD32b + : resident Ig-24 regulated), one with sterol-synthesizing function (MSMO1 + )(32), one with potential scavenger 25 function (SCD + ) (33), one with potential healing and/or profibrotic genes (FN1 + )(34), one with a 26 higher expression of inflammatory markers (CTSC + : M1-like, recruited, inflammatory), one with 27 several eukaryotic initiation factors (EIF) (35) and two AM populations in the cell cycle (18, 36). 28

Of the latter, one had G2/M phase transcripts while the other had S phase transcripts. These data 29

suggest that each AM cluster may have distinct functional properties, some of which have been 30 ascribed to AMs previously (Table 2 ). Fig 1C shows the most differentially expressed genes that 31 were also expressed in the majority of the cells in each cluster. We also analyzed the incoming and 32

outgoing ligand/receptor signaling network for each cluster (Fig S6) to gain insight into how the 33 clusters may interact with each other. 34 35

To further evaluate similarities and differences between AM subsets based on their ontogeny, we 36 performed pseudotime trajectory analysis using Slingshot (37) (Fig 1D) . This suggested that 37

CD32b + AMs have recently differentiated, whereas cycling AMs were found at the end of the 38 trajectory. Next, we examined whether any of the identified AM clusters could be classified as 39 M1-or M2-polarized macrophages based on known genes (38) . In stable BAL samples, cluster 5 40 differentially expressed 4 genes associated with M1 polarization while cluster 8 differentially 1 expressed 3 genes associated with M2 polarization (Fig S5C) . Overall, however, expression of 2 canonical M1-and M2-associated genes was distributed over multiple cell clusters, rather than 3 being restricted to specific clusters. Since fetal yolk sac-derived and recruited monocyte-derived 4 macrophages can contribute to the AM compartment, we further examined differential expression 5 of genes associated with these populations (15). Interestingly, the M1-like CTSC+ cluster 6 differentially expressed CD14, CD74, APOE and C1QC -which are associated with monocyte-7 derived macrophage populations. The M2-like CD32b+ cluster, by contrast, most strongly 8 expressed S100A10, CRIP1, S100A4, and MRC1 which are associated with tissue-resident yolk 9

sac-derived AM (Fig 1E) . Taken together, these observations suggest that the CTSC+ and CD32b+ 10 clusters express genes classically associated with M1-like monocyte-derived AMs and M2-like 11 resident AMs, respectively; however, these two populations are only a minority of AMs in LT 12 BAL. 13 14 Unique macrophages are found in BAL samples from patients with ALAD 15

Next we compared the transcriptomes of AMs from stable LT patients to those from patients with 16

ALAD. As with the stable samples, we analyzed 1000 randomly selected AMs from ALAD 17 samples and observed a similar degree of AM heterogeneity (Fig 2A, S7) , with 13 distinct clusters. 18

However, review of the top differentially expressed genes and pathway analysis (Fig S8)  19 demonstrated that these clusters differed compared to those in stable samples. To identify 20 similarities and differences between AM subsets in the two groups, we used Clustermap to 21 compare differentially expressed genes by cluster from stable (data file S1) and ALAD (data file 22 S2) samples. The two groups shared 11 common AM subsets, whereas there were two unique 23 clusters in ALAD samples (Fig 2B-C and Fig S9A) ; these clusters expressed either interferon-24 stimulated genes (ISGs) or metallothioneins (MTs). Comparing the frequency of equivalent pairs 25 of clusters in stable and ALAD samples, there were three additional clusters present at lower 26 relative frequency (>20% difference in representation between the two groups) in stable samples 27 ( Fig 2C) . In addition, while some ALAD AMs were in G2/M phase (Fig S9B) , cells in this phase 28 of the cell cycle only formed a distinct cluster in samples from stable patients. This observation 29

suggests that there may be less transcriptional diversity among AMs in stable compared to ALAD 30 samples, allowing greater resolution of S and G2/M phase AMs; alternatively, ALAD AMs might 31 be more rapidly cycling, decreasing our ability to resolve differences between these phases of the 32 cell cycle. 33 34 We delved deeper into the niche occupied by ISG and MT AMs by examining top differentially 35 expressed genes, pathways and potential interactions of these cell clusters. Several highly 36 expressed transcripts in the ISG cluster are involved in pro-inflammatory pathways, including 37

IFITM2, IFITM3, ISG15, and ISG20 in addition to CXCL10; the products of these genes promote 38 lymphocyte trafficking and B cell activation in the transplantation setting (39) as well as in other 39 inflammatory diseases (40). Our analysis showed that ISG AMs potentially interact with other 40

AMs via a GALECTIN9-HAVCR2 pathway (Fig 2D top panel) , which is known to promote 41 macrophage-mediated inflammation (41, 42). Similarly, MT AMs are likely to interact with other 1

AMs through the RESISTIN-CAP1 pathway, which induces a pro-inflammatory response in 2 macrophages (43) (Fig 2D, bottom panel) . 3 4

Next, we examined the differentiation of MT and ISG AMs using pseudotime analysis. This 5 revealed that these cells arise at a similar stage ( Fig 2E) . Despite small differences in pseudotime 6 branching, the general trajectory patterns for ALAD and stable samples were similar. In ALAD, 7

MT and ISG AMs were in the early-intermediate part of the pseudotime trajectory, suggesting that 8 they may have recently differentiated from recruited monocytes in response to specific stimuli. 9 10 CXCL10+ AMs exhibit a pro-inflammatory phenotype in vitro 11

To determine whether AMs associated with ALAD could be identified based on cell-associated 12 proteins, we obtained an independent set of 7 BAL samples (n=4 stable and n=3 ALAD) and 13 stimulated the cells overnight in the presence or absence of lipopolysaccharide (LPS). We used 14 flow cytometry to identify ISG AMs (full gating strategy is presented in Fig S10) by staining for 15

CD163 and intracellular CXCL10. The percentage of CXCL10-expressing AMs was lower in BAL 16 samples from stable patients but, with LPS stimulation, the proportion of CXCL10+ AMs in 17

increased to the level seen in ALAD samples ( Fig 3A) . However, no further increase in CXCL10+ 18

AMs was seen in ALAD samples in response to LPS, suggesting that only a limited number of 19

AMs can acquire this phenotype. We analyzed cytokine and chemokine levels in the AM culture 20 supernatants using a 13-parameter multiplexed cytokine assay. In keeping with the greater 21 presence of CXCL10+ AMs in ALAD samples, IL-6, TNFa, IFNg and CXCL10 were released in 22

greater quantities by AMs from ALAD compared to stable samples ( Fig 3B) . These findings 23 validate the observation that ISG AMs are associated with ALAD in LT patients. 24 25

Similarities and differences between AM subsets in ALAD and publicly available BAL datasets 26

To determine whether ISG and MT AMs are associated with inflammation outside the LT context, 27

we investigated publicly available scRNAseq data from two studies, one focusing on the cellular 28 composition of BAL from healthy controls (15) and another on BAL from COVID-19 patients 29 (26) . In healthy controls, Mould et al. described two macrophage clusters (m5 and m6) with 30 features of ISG and MT AMs, respectively (15). We therefore integrated their data with our ALAD 31 samples ( Fig 4A) . Based on expression level and cell frequency, the ALAD samples contributed 32 more AMs to these clusters than did healthy control BAL samples (Fig 4B-C) . We also found ISG 33 and MT AMs in BAL samples from COVID-19 patients (clusters 0 and 1 for ISG and 22 for MT 34

in Liao et al. (26) ). In keeping with the notion that these AM populations mediate lung 35

inflammation, most AMs in these clusters originated from patients with severe, rather than 36 moderate, COVID-19 (Fig 4D-F) . Clusters expressing the top differentially expressed genes in 37 ISG and MT AMs are shown in Fig 4E- ALAD-associated macrophages are found in CLAD lung tissue 40

We next studied the transcriptomes of macrophages from fresh explanted CLAD lung tissue 1 samples obtained at the time of re-transplantation for bronchiolitis obliterans syndrome (n=4) 2 using the same approach taken stable BAL samples. CLAD tissue macrophages exhibited 3 heterogeneity (Fig 5A) . A review of the top differentially expressed genes ( Fig S11) demonstrated 4 that many of these clusters differed from BAL AMs, presumably because these samples contain 5

both AMs and interstitial macrophages. Importantly, however, CLAD lung macrophages included 6 distinct clusters with ISG and MT gene signatures (Fig 5B) . The current consensus on healthy and 7 diseased lung tissue macrophages holds that there are three main populations: FABP4 hi , SPP1 hi , 8

and FCN1 hi (19, [44] [45] [46] . Although these three genes are represented in different CLAD lung 9 macrophages, they do not account for all BAL AMs and CLAD tissue macrophages in our samples 10 or those of others ( Fig 5C) . Nevertheless, FABP4 expression -which has been associated with 11

inflammation (44) suggested an exceptionally long-term persistence of donor AM (49, 50). We chose to examine this 26 question using an SNV calling algorithm that allowed us to infer donor and recipient origins of 27 cells -without reference to genomic sequence data -by determining which SNVs were present in 28 the majority of epithelial cells in the sample (Fig 6A) . We observed replacement of donor-derived 29 by recipient-derived AM over time post-transplant ( Fig 6B) , but in contrast to prior reports, most 30 of the replacement occurs within the first-year post-transplant. At 3 months post-transplant, most 31 AM were of donor origin; at 12 months post-transplant, only 10% of AM were donor-derived and 32

by 24 months, AM were exclusively recipient-derived ( Fig 6C) . These findings reveal a somewhat 33 faster replacement of donor AMs than has been reported previously. 34 35

Discussion 1 2

In this study, we used scRNAseq to compare macrophage transcriptional states in BAL samples 3 from LT recipients with either stable lung function or ALAD, and from explanted CLAD lung 4 tissue. We focused on macrophages because they represent the majority of BAL cells, and the 5 behaviour of AMs in relation to lung allograft dysfunction has not been investigated in detail. Our 6 data reveal a previously unappreciated diversity in LT AMs, with evidence for functional 7 specialization among the populations. In agreement with previous reports (18, 51, 52), our data 8

show that the M1 vs. M2 paradigm inadequately captures AM diversity. 9 10

We observed substantial differences -despite our small sample size and the high genetic diversity 11 associated with human subjects -between stable and ALAD patients. Most notably, ISG and MT 12

AMs were uniquely represented in ALAD samples. An examination of differentially expressed 13 genes in ISG AMs suggested that different pro-inflammatory cascades have been induced, 14 probably in response to IFNg, including guanylate-binding proteins (GBPs), cytokines and 15 chemokines (CXCL10, CCL4, and CCL2), in addition to several members of the ISG family. 16

Although the IFNg response in macrophages is typically associated with infection, it is likely that 17 ISG AMs in our ALAD samples were responding to alloimmune-mediated inflammation since 18 patients with infection were excluded. However, it remains unclear whether this cluster of cells 19

represents a developmentally distinct macrophage population, or whether the activation of an ISG 20 program simply reflects the effects of IFNg on a susceptible subset of AMs. Since these cells were 21 absent from stable BAL samples that underwent scRNAseq and only represented in small 22

proportions of stable samples subjected to flow cytometry, we favour the latter explanation. 23

Importantly, AMs isolated from stable patients produced less CXCL10 -one of the most 24 differentially expressed genes in the ISG cluster -than AMs from ALAD patients. This finding 25 validates the scRNAseq observations at a phenotypic level. Nevertheless, it was possible to elicit 26 CXCL10 expression in stable AMs that was comparable to that of ALAD AMs using LPS, 27

indicating that the AM phenotypes we describe here are dynamic. 28 29

MT AMs -also uniquely associated with ALAD -have not previously been shown to participate 30 in alloimmunity. MTs are a family of metal-binding proteins that maintain homeostasis of zinc and 31 copper, mitigate heavy metal toxication, and alleviate superoxide stress. They also mediate 32 inflammatory responses and antimicrobial defense (53). It has been suggested that MT expression 33 in macrophages is required for pro-inflammatory responses (54). We are unaware of previous data 34

implicating MT-expressing macrophages in LT; whether they participate in the pathogenesis of 35 allograft dysfunction requires further investigation. 36 37

Nevertheless, our observation that ISG and MT macrophages are present in CLAD lung tissue 38 confirms their relationship to progressive allograft dysfunction. Further, that these cellular 39 populations are associated with disease severity in COVID-19 and are present in only small 40 numbers in healthy lungs supports their role in lung inflammation more generally. Identification 1 of specific disease-associated macrophages may facilitate the discovery of targeted therapies for 2 inflammatory lung diseases and lung allograft dysfunction in the future. 3 4

In support of this notion, we also observed remarkably extensive cell-cell communication networks 5

amongst AMs in both stable and ALAD patients, suggesting the existence of complex feedback 6 and feed-forward loops between these cells in the bronchoalveolar niche; in contrast, 7 communication between AMs and T cells appeared to be more limited, with predicted pathways 8 primarily restricted to chemokine signalling. These findings will require further study, but they 9

suggest that control of the inflammatory tone of the alveolar space in LT recipients is subject 10 primarily to complex inter-relationships between AMs rather than AM-T cell interactions. 11 12

Our SNV data confirmed previous reports (49) immune responses. While these are undoubtedly central to lung allograft loss, the appearance of 28 specific AM gene expression programs during ALAD suggests that these cells may contribute 29

actively to the loss of lung function and may therefore represent important mechanistic targets. 30 31 32 Acknowledgements 1

The authors wish to thank Marcelo Cuesta, Iva Avramov and Max Niit of the Toronto Lung 2

Transplant Program Biobank for assistance in sample handling. We thank Amber Xue for help 3 with the multiplexed cytokine assay. We also thank Gurbaksh Basi and Iulia Cirlan of the 4 Princess Margaret Genomics Centre for running scRNAseq. Functional annotation of AMs was performed as in Fig 1B. (B) Clustermap analysis shows 11 23 AM clusters shared between ALAD (top) and stable (bottom) BAL. ALAD clusters 5 and 12 24

were unique to ALAD while stable cluster 10 was unique to stable samples. 

Dynamics of human monocytes and airway macrophages during 3 healthy aging and after transplant

Single cell RNA sequencing 5 identifies unique inflammatory airspace macrophage subsets

Defining the 8

Activated Fibroblast Population in Lung Fibrosis Using Single-Cell Sequencing

SARS-CoV-2 receptor 12 ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

Single-Cell Transcriptomics of Human and 17

Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and 18 Species

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the 27 Pathobiology of Pulmonary Fibrosis

The Human Lung Cell Atlas: A High-Resolution Reference Map of the Human Lung in 32 Health and Disease

Single-cell RNA-seq data analysis on the receptor 34 ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-35 nCoV infection

Single-cell RNA sequencing demonstrates the molecular and cellular 39 reprogramming of metastatic lung adenocarcinoma

Reference-based analysis of lung single-cell sequencing 42 reveals a transitional profibrotic macrophage

Macrophage Polarization: Different Gene 1 Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated 2 Macrophages

Upregulation of IFN-Inducible 6 and Damage-Response Pathways in Chronic Graft-versus-Host Disease

Accelerating 9 Medicines Partnership Rheumatoid A

IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage 11 phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue 12 inflammation

The Tim3-galectin 9 pathway induces 15 antibacterial activity in human macrophages infected with Mycobacterium tuberculosis

Cis association of galectin-9 with Tim-3 differentially regulates IL-19

IL-23 expressions in monocytes via TLR signaling

Human resistin 21 stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-22 kappaB-dependent pathway

Proliferating SPP1/MERTK-expressing 25 macrophages in idiopathic pulmonary fibrosis

Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell 29 populations in idiopathic pulmonary fibrosis

Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis

Fate mapping analysis reveals that adult 36 microglia derive from primitive macrophages

Fate 39 mapping reveals origins and dynamics of monocytes and tissue macrophages under 40 homeostasis

Long-Term 42 Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That 43 Influences Donor-Specific Immune Responses

Long-term persistence of human 2 donor alveolar macrophages in lung transplant recipients

Abandoning M1/M2 for a Network Model of Macrophage 4 Function

Origin and ontogeny of lung macrophages: from mice to 6 humans

Metallothioneins: Emerging Modulators in Immunity 8 and Infection

Metallothionein is 10 required for zinc-induced expression of the macrophage colony stimulating factor gene

Donor dendritic cell-derived exosomes 14 promote allograft-targeting immune response

Generation and persistence of human tissue-18 resident memory T cells in lung transplantation